LANOXIN PG digoxin 62.5microgram tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

lanoxin pg digoxin 62.5microgram tablet bottle

aspen pharma pty ltd - digoxin, quantity: 0.0625 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; indigo carmine; oxidised maize starch; rice starch - indications as at 26 july 2000 : congestive heart failure - lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Lanoxin Adult 500mcg/2mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lanoxin adult 500mcg/2ml injection ampoule

aspen pharma pty ltd - digoxin, quantity: 0.25 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; dibasic sodium phosphate; propylene glycol; water for injections; ethanol - indications as at 26 july 2000 : congestive heart failure - lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Lanoxin Infants 50mcg/2mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lanoxin infants 50mcg/2ml injection ampoule

aspen pharma pty ltd - digoxin, quantity: 25 microgram/ml - injection, solution - excipient ingredients: ethanol; propylene glycol; citric acid; dibasic sodium phosphate; water for injections - indications as at 26 july 2000 : congestive heart failure - lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Aortic bi-leaflet heart valve prosthesis/biologic-polymer aorta graft 502AG Australia - English - Department of Health (Therapeutic Goods Administration)

aortic bi-leaflet heart valve prosthesis/biologic-polymer aorta graft 502ag

medtronic australasia pty ltd - 60423 - aortic bi-leaflet heart valve prosthesis/biologic-polymer aorta graft - the device's purpose is for use in cases where both replacement of the aortic valve and replacement of the aorta are indicated. the device's purpose is for the use in cases where both replacement of the aortic valve and replacement of the aorta are indicated.

EZ Steer Bi-Directional Ablation Catheter (Thermocouple) - Catheter, cardiac, electrophysiological mapping Australia - English - Department of Health (Therapeutic Goods Administration)

ez steer bi-directional ablation catheter (thermocouple) - catheter, cardiac, electrophysiological mapping

johnson & johnson medical pty ltd - 44867 - catheter, cardiac, electrophysiological mapping - a 7f multi-electrode non-navigational bi-directional deflectable electrophysiology catheter with a 4mm tip and a single thermocouple temperature sensor for cardiac electrophysiological mapping (stimulation and recording) and, when used in conjunction with a radiofrequency generator, for cardiac ablation

EZ Steer DS Bi-Directional Ablation Catheter - Cardiac radio-frequency ablation system catheter Australia - English - Department of Health (Therapeutic Goods Administration)

ez steer ds bi-directional ablation catheter - cardiac radio-frequency ablation system catheter

johnson & johnson medical pty ltd - 61785 - cardiac radio-frequency ablation system catheter - a 7f multi-electrode non-navigational, bi-directional, deflectable electrophysiology catheter with an 8mm tip and dual temperature sensors for cardiac mapping and ablation for cardiac electrophysiological mapping (stimulation and recording) and, when used in conjunction with a radiofrequency generator, for cardiac ablation.

EZ Steer Nav Bi-Directional Ablation Catheter (Thermocouple) - Catheter, cardiac, electrophysiological mapping Australia - English - Department of Health (Therapeutic Goods Administration)

ez steer nav bi-directional ablation catheter (thermocouple) - catheter, cardiac, electrophysiological mapping

johnson & johnson medical pty ltd - 44867 - catheter, cardiac, electrophysiological mapping - a 7f multi-electrode navigational bi-directional deflectable electrophysiology catheter with a 4mm tip and single thermocouple temperature sensor for cardiac electrophysiological mapping (stimulation and recording) and, when used in conjunction with a radiofrequency generator, for cardiac ablation

ThermoCool Smart Touch Bi-Directional Navigation Catheter - Cardiac radio-frequency ablation system catheter Australia - English - Department of Health (Therapeutic Goods Administration)

thermocool smart touch bi-directional navigation catheter - cardiac radio-frequency ablation system catheter

johnson & johnson medical pty ltd - 61785 - cardiac radio-frequency ablation system catheter - the catheter is a steerable multi-electrode, luminal catheter with a deflectable tip designed to facilitate electrophysiological mapping of the heart and to transmit radiofrequency current to the catheter tip electrode for ablation purposes. for ablation, the catheter is used in conjunction with an rf generator and a dispersive pad. the catheter has a high torque shaft with a bi-directional deflectable tip section containing an array of electrodes. compatible with carto 3 navigation system. thermocool smart touch bi-directional navigation catheter is indicated for catheter based cardiac electrophysiological mapping (stimulating and recording) and, when used in conjunction with a radiofrequency generator, for cardiac ablation. this catheter provides a real-time measurement of contact force between the catheter tip and heart wall, as well as location information when used with carto 3 navigation system.

SABAKEM MEPIQUAT 38SL COTTON GROWTH REGULATOR Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sabakem mepiquat 38sl cotton growth regulator

sabakem pty ltd - mepiquat present as the chloride - aqueous concentrate - mepiquat present as the chloride ammonium-quaternary active 38.0 g/l - growth regulator - cotton - control excess growth of vegetation | regulate fruiting | regulate vegetative growth

APPARENT BROADBLADE HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apparent broadblade herbicide

titan ag pty ltd - flumetsulam - water dispersible granule - flumetsulam pyrimidine-sulfonamide active 800.0 g/kg - herbicide - agricultural non-crop areas | arrowleaf clover seed crop | barley | barley - salvage spray | barley - stirling variety | barley - amsinckia,yellow burrweed or burr grass | annual or common ragweed | anoda weed | ball mustard | black pigweed - suppression | bladder ketmia - suppression | boggabri weed | buchan weed | calepina | caltrop or yellow vine | capeweed | capeweed - suppression | charlock | chickweed - suppression | cotton (volunteer) | cotulas | deadnettle | dwarf marigold | fat hen | fierce thornapple - suppression | fumitory | fumitory - suppression | hedge or wild mustard | indian hedge mustard | lesser swinecress or bittercress | lupins | marsh or smallflower mallow | marshmallow - suppression | mustard | narrow leaf lupin | new zealand spinach | paterson's curse | peppercress | pheasant's-eye or adonis | red pigweed | sand plain or w.a. blue lupin | shepherd's purse | spurry - suppression | stagger weed | three cornered jack or doublegee | three-horned bedstraw | turnip weed | volunteer canola | volunteer cotton - roundup ready | ward's weed | wild gooseberry - suppression of | wild radish or radish weed | wild turnip | wir